Zobrazeno 1 - 10
of 10
pro vyhledávání: '"C Blázquez Romero"'
Autor:
MA Toledo Davia, N Labrador Andújar, AR Rubio Salvador, C Blázquez Romero, L Torralba Fernández, C Jiménez Méndez, R Prieto Galindo, P Aguado Barroso, E Gómez Fernández, P Moya Gomez
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e4f38569f666fd150ae2e7b7eaa5785
https://doi.org/10.1136/ejhpharm-2023-eahp.60
https://doi.org/10.1136/ejhpharm-2023-eahp.60
Autor:
AA García Sacristán, S Gonzalez Suarez, AR Rubio Salvador, R López Álvarez, P Moya Gómez, A Dominguez Barahona, H Quiros Ambel, C Blázquez Romero
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Infectious diseases are one of the most frequent reasons for consultation in the Emergency Department (ED), as well as one of the main causes of mortality and admission in the hospital. According to recent studies, antimicrobials are the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5377cf8e659f7b2a66e16d3e06f456b3
https://doi.org/10.1136/ejhpharm-2019-eahpconf.203
https://doi.org/10.1136/ejhpharm-2019-eahpconf.203
Autor:
N Labrador Andujar, AA García Sacristán, R López Álvarez, P Moya Gómez, A Dominguez Barahona, S Gonzalez Suarez, AR Rubio Salvador, C Blázquez Romero
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Daratumumab is a human monoclonal antibody that binds to CD38 protein, expressed in a high level in the tumour cells of multiple myeloma (MM), inhibiting their proliferation. It has been authorised in combination with bortezomib, melphalan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4572308290a23b719c3c158fe2846a61
https://doi.org/10.1136/ejhpharm-2019-eahpconf.282
https://doi.org/10.1136/ejhpharm-2019-eahpconf.282
Autor:
H Quiros Ambel, A Dominguez Barahona, C Blázquez Romero, N Labrador Andujar, P Moya Gómez, AA García Sacristán, FJ Manzano Lista, JM Martínez Sesmero
Publikováno v:
Drug information and pharmacotherapy.
Background One of the main objectives in the adequacy of HIV antiretroviral treatment is to find the drug or set of drugs that allow the best results to be obtained for the patient and to try to support this medication over time. Since the introducti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f628c9786d6218d0a8a60641909b212
https://doi.org/10.1136/ejhpharm-2017-000640.274
https://doi.org/10.1136/ejhpharm-2017-000640.274
Autor:
AI Fernández Marchante, BM Muñoz Cejudo, MM Alañón Pardo, A Martín Siguero, MT Franco Sereno, VL Areas del Águila, C Encinas Barrios, C Blázquez Romero
Publikováno v:
European Journal of Hospital Pharmacy. 21:A166.2-A166
Background Drugs returned by patients have to be managed properly. Purpose To analyse drugs returned by patients and the associated financial impact after the implementation of a quality system (corrective action to ensure traceability of these drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5737f0e6621d3ea4a4dab7d5439e292
https://doi.org/10.1136/ejhpharm-2013-000436.407
https://doi.org/10.1136/ejhpharm-2013-000436.407
Autor:
VL Areas del Águila, A Martín Siguero, MM Alañón Pardo, MT Franco Sereno, C Encinas Barrios, AI Fernández Marchante, BM Muñoz Cejudo, C Blázquez Romero
Publikováno v:
European Journal of Hospital Pharmacy. 21:A198.3-A199
Background Satisfaction surveys are an important tool for ascertaining patient opinions. Purpose To evaluate the degree of satisfaction with interferon beta-1a pre-filled pens and patient preferences. Materials and methods We conducted a survey of pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27d46e8a0cf5cafcc50d44da8dd62bca
https://doi.org/10.1136/ejhpharm-2013-000436.485
https://doi.org/10.1136/ejhpharm-2013-000436.485
Autor:
AI Fernández Marchante, S Ibañez Garcia, C Blázquez Romero, A Martín Siguero, C Encinas Barrios, MT Franco Sereno, BM Muñoz Cejudo, VL Areas del Águila
Publikováno v:
European Journal of Hospital Pharmacy. 20:A120.2-A120
Background Hepatitis C virus (HCV) infection is a major health problem in the western world. Current treatment with interferon (IFN) and ribavirin (RBV) is able to produce a sustained virological response in approximately 50% of patients with genotyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::607c634205291af769ebd0ab6ca32871
https://doi.org/10.1136/ejhpharm-2013-000276.333
https://doi.org/10.1136/ejhpharm-2013-000276.333
Autor:
R. Pérez Serrano, C Blázquez Romero, MT Franco Sereno, C Encinas Barrios, A Puebla Martin, S Ibañez Garcia, A Martín Siguero, A Ambrós Checa, BM Muñoz Cejudo, I Vázquez Rodriguez-Barbero
Publikováno v:
European Journal of Hospital Pharmacy. 20:A138.1-A138
Background The increase in drug spending and the decrease in resources make it necessary to look for strategies for minimising costs. Purpose To describe the strategy for administering high-consumption intravenous drugs (IVd) directly and estimating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22685ec7893e0acee3b4cf4c25127b6e
https://doi.org/10.1136/ejhpharm-2013-000276.381
https://doi.org/10.1136/ejhpharm-2013-000276.381
Autor:
S Ibañez Garcia, M.A. Bocanegra Bolívar, M.L. Moreno Perulero, A Martín Siguero, C Blázquez Romero, BM Muñoz Cejudo, C Encinas Barrios, E Vila Torres
Publikováno v:
European Journal of Hospital Pharmacy. 19:127.2-127
Background A growing body of evidence suggests that proton pump inhibitors (PPIs) may adversely interact with clopidogrel, diminishing the antiplatelet effect. The potential for increased risk of thrombotic complications warrants cautious use of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fe3a38d45a93fe6b65c1f72a19e6059
https://doi.org/10.1136/ejhpharm-2012-000074.112
https://doi.org/10.1136/ejhpharm-2012-000074.112
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.